Apogee Therapeutics Statistics

Total Valuation

APGE has a market cap or net worth of $3.29 billion. The enterprise value is $2.51 billion.

Market Cap	3.29B
Enterprise Value	2.51B

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

APGE has 58.49 million shares outstanding. The number of shares has increased by 1,022.94% in one year.

Shares Outstanding	58.49M
Shares Change (YoY)	+1,022.94%
Shares Change (QoQ)	+12.60%
Owned by Insiders (%)	2.06%
Owned by Institutions (%)	78.92%
Float	29.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.26
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 27.70, with a Debt / Equity ratio of 0.01.

Current Ratio	27.70
Quick Ratio	27.47
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.73% and return on invested capital (ROIC) is -20.17%.

Return on Equity (ROE)	-26.73%
Return on Assets (ROA)	-19.30%
Return on Capital (ROIC)	-20.17%
Revenue Per Employee	n/a
Profits Per Employee	-$1.30M
Employee Count	91
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +257.42% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+257.42%
50-Day Moving Average	52.89
200-Day Moving Average	48.35
Relative Strength Index (RSI)	56.79
Average Volume (20 Days)	332,728

Short Selling Information

The latest short interest is 6.87 million, so 11.74% of the outstanding shares have been sold short.

Short Interest	6.87M
Short Previous Month	7.23M
Short % of Shares Out	11.74%
Short % of Float	23.63%
Short Ratio (days to cover)	14.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-143.76M
Pretax Income	-103.55M
Net Income	-118.49M
EBITDA	n/a
EBIT	-143.76M
Earnings Per Share (EPS)	-$2.41

Full Income Statement

Balance Sheet

The company has $676.23 million in cash and $4.08 million in debt, giving a net cash position of $785.54 million or $13.43 per share.

Cash & Cash Equivalents	676.23M
Total Debt	4.08M
Net Cash	785.54M
Net Cash Per Share	$13.43
Equity (Book Value)	773.64M
Book Value Per Share	13.23
Working Capital	657.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$110.57 million and capital expenditures -$569,000, giving a free cash flow of -$111.14 million.

Operating Cash Flow	-110.57M
Capital Expenditures	-569,000
Free Cash Flow	-111.14M
FCF Per Share	-$1.90

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,022.94%
Shareholder Yield	-1,022.94%
Earnings Yield	-3.60%
FCF Yield	-3.37%

Analyst Forecast

The average price target for APGE is $75.20, which is 33.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$75.20
Price Target Difference	33.50%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	1.91%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2